| Kidney improvement sustained by Abbott drug-study - Reuters |
|
|
Reuters The oral drug, bardoxolone methyl, is the first medicine to demonstrate improvement in kidney function in patients with the deadly disease and could delay the need for expensive and inconvenient kidney dialysis, researchers said. ... Abbott Inflammation Drug Reverses Kidney Decline in Diabetics, Study Finds Bloomberg Bardoxolone Data Shows Patient Improvement Drug Discovery & Development New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone |